A Note From Stephanie Link
Alternatively, we offer videos with our experts for easy viewing. Take a look at our Columnist Conversation box where our contributors chat amongst themselves and feel free to reach out to any of them directly and give them feedback on their articles in the comment section. We also provide daily upgrades and downgrades by Wall Street analysts and important earnings estimate changes and call outs to key research reports.
Below are a few article highlights from this past week:
On RealMoney: Matthew Bradbard -- one of our newest RM contributors talks about the trade of a lifetime in the Eurodollar :
I am going out on a limb here, and if there is no change in interest rates in the next 27 months I will be wrong.
If and when rates move higher, bearish exposure in long-dated Eurodollar contracts could be the preeminent trade of my career. Not only do I see the potential for great profit, I like the outlook in regards to risk.
This is NOT the euro currency that is trading at roughly $1.26, but rather the debt instrument tied to the short end of the yield curve. As defined on the CME website: Eurodollar Time Deposit having a principal value of USD $1,000,000 with a three-month maturity. Quoted in IMM Three-Month LIBOR index points or 100 minus the rate on an annual basis over a 360 day year (e.g., a rate of 2.5% shall be quoted as 97.50). 1 basis point = .01 = $25. ( Continued)
Meena Krishnamsetty -- also a new RM team player looks at the latest investments being made by high profile investors :
At Insider Monkey, we track 13F SEC filings from many hedge funds and other large investors, including the investment activities of billionaires and their investment teams. For today's piece, we'll focus on the consumer sector: Within that space, here are the five largest new positions from billionaires.
First, Bill Ackman's Pershing Square initiated a position of about 22 million shares in Procter & Gamble (PG) -- which, according to the fund's 13F filing, made this the second-largest position in the fund's portfolio. Shares of the personal-products giant -- whose brands include Pantene, Gillette, Pampers and Duracell -- has low market exposure, with a beta of 0.3, and the company pays a 3.3% dividend. It has also reported solid year-over-year earnings growth in the last quarter. The stock, meanwhile, trades at 18x trailing earnings. While that may be a bit high, Wall Street analysts believe earnings will continue to grow -- and, on a forward basis, its price-to-earnings ratio is 16x. Given the dividend yield, this may be a fairly valued defensive pick. ( Continued)